Talk:Interleukin
From Wikipedia, the free encyclopedia
 |
This article is within the scope of WikiProject Medicine. Please visit the project page for details or ask questions at the doctor's mess. |
| Start | This page has been rated as Start-Class on the quality assessment scale |
| Mid | This article has been rated as Mid-importance on the importance assessment scale |
 |
This article is within the scope of the Molecular and Cellular Biology WikiProject. To participate, visit the WikiProject for more information. The WikiProject's current monthly collaboration is focused on improving Restriction enzyme. |
||
| Start | This article has been rated as start-Class on the assessment scale. |
||
| Mid | This article is on a subject of Mid-importance within molecular and cellular biology. | ||
|
Article Grading: The article has been rated for quality and/or importance but has no comments yet. If appropriate, please review the article and then leave comments here to identify the strengths and weaknesses of the article and what work it will need. |
|||
[edit] User: Zefito's contribution
User Zefito's contribution was directly from "Fisman EZ, Motro M, Tenenbaum A: Cardiovascular diabetology in the core of a novel interleukins classification: the bad, the good and the aloof. Cardiovasc Diabetol 2003, 12;2:11.", which may be copyrighted.
References are not in Wiki style. --Leeearnest 17:05, 17 March 2007 (UTC)
[edit] Article review
This information has been reviewed by Nicole Graf, RN. --165.20.104.30 03:24, 20 October 2007 (UTC)
[edit] Differentiation
Il-6 and Il-1B have been recently shown to promote differentiation/neurogenesis in Neural Stem/Progenitor Cells, as per Barko et al., 2006). —Preceding unsigned comment added by 165.82.80.22 (talk) 15:14, 5 March 2008 (UTC)
